Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Associations between change in blood pressure and functional outcome, early events and death: results from the Efficacy of Nitric Oxide in Stroke trial.

Sandset EC, Appleton JP, Berge E, Christensen H, Gommans J, Krishnan K, Ntaios G, Phillips S, Pocock S, Sprigg N, Woodhouse LJ, Bath PM; ENOS trial investigators*.

J Hypertens. 2019 Oct;37(10):2104-2109. doi: 10.1097/HJH.0000000000002154.

PMID:
31246895
2.

It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis.

Appleton JP, Woodhouse LJ, Belcher A, Bereczki D, Berge E, Caso V, Chang HM, Christensen HK, Collins R, Gommans J, Laska AC, Ntaios G, Ozturk S, Sare GM, Szatmari S, Wang Y, Wardlaw JM, Sprigg N, Bath PM.

Stroke Vasc Neurol. 2019 Mar 19;4(1):28-35. doi: 10.1136/svn-2019-000232. eCollection 2019 Mar.

3.

Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke.

Appleton JP, Woodhouse LJ, Bereczki D, Berge E, Christensen HK, Collins R, Gommans J, Ntaios G, Ozturk S, Szatmari S, Wardlaw JM, Sprigg N, Rothwell PM, Bath PM; ENOS Investigators.

Stroke. 2019 Feb;50(2):405-412. doi: 10.1161/STROKEAHA.118.023190.

4.

Central masked adjudication of stroke diagnosis at trial entry offered no advantage over diagnosis by local clinicians: Secondary analysis and simulation.

Godolphin PJ, Hepburn T, Sprigg N, Walker L, Berge E, Collins R, Gommans J, Ntaios G, Pocock S, Prasad K, Wardlaw JM, Bath PM, Montgomery AA.

Contemp Clin Trials Commun. 2018 Nov 10;12:176-181. doi: 10.1016/j.conctc.2018.11.002. eCollection 2018 Dec. Review.

5.

Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.

Godolphin PJ, Montgomery AA, Woodhouse LJ, Bereczki D, Berge E, Collins R, Díez-Tejedor E, Gommans J, Lees KR, Ozturk S, Phillips S, Pocock S, Prasad K, Szatmari S, Wang Y, Bath PM, Sprigg N; ENOS Investigators.

PLoS One. 2018 Nov 26;13(11):e0208142. doi: 10.1371/journal.pone.0208142. eCollection 2018.

6.

Impact of General Practitioner Transient Ischemic Attack Training on 90-Day Stroke Outcomes: Secondary Analysis of a Cluster Randomized Controlled Trial.

Ranta A, Dovey S, Gommans J, Tilyard M, Weatherall M.

J Stroke Cerebrovasc Dis. 2018 Jul;27(7):2014-2018. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.064. Epub 2018 Mar 30.

PMID:
29610038
7.

Appropriateness of general practitioner imaging requests for transient ischaemic attack patients: secondary analysis of a cluster randomised controlled trial.

Ranta A, Weatherall M, Gommans J, Tilyard M, Odea D, Dovey S.

J Prim Health Care. 2017 Jun;9(2):131-135. doi: 10.1071/HC17005.

PMID:
29530224
8.

The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis.

Graham C, Lewis S, Forbes J, Mead G, Hackett ML, Hankey GJ, Gommans J, Nguyen HT, Lundström E, Isaksson E, Näsman P, Rudberg AS, Dennis M.

Trials. 2017 Dec 28;18(1):627. doi: 10.1186/s13063-017-2385-6.

9.

Infections Up to 76 Days After Stroke Increase Disability and Death.

Learoyd AE, Woodhouse L, Shaw L, Sprigg N, Bereczki D, Berge E, Caso V, Christensen H, Collins R, Czlonkowska A, El Etribi A, Farr TD, Gommans J, Laska AC, Ntaios G, Ozturk S, Pocock SJ, Prasad K, Wardlaw JM, Fone KC, Bath PM, Trueman RC; ENOS Trial investigators.

Transl Stroke Res. 2017 Dec;8(6):541-548. doi: 10.1007/s12975-017-0553-3. Epub 2017 Jul 27.

10.

Impact and implementation of a sustainable regional telestroke network.

Ranta A, Lanford J, Busch S, Providence C, Iniesta I, Rosemergy I, Wilson A, Cariga P, Richmond V, Gommans J.

Intern Med J. 2017 Nov;47(11):1270-1275. doi: 10.1111/imj.13557.

PMID:
28742223
11.

Antimicrobial resistance in New Zealand: the evidence and a call for action.

Pullon HW, Gommans J, Thomas MG, Metcalf S, Grainger R, Wild H.

N Z Med J. 2016 Oct 28;129(1444):103-110.

PMID:
27806034
12.

Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial.

Krishnan K, Scutt P, Woodhouse L, Adami A, Becker JL, Cala LA, Casado AM, Chen C, Dineen RA, Gommans J, Koumellis P, Christensen H, Collins R, Czlonkowska A, Lees KR, Ntaios G, Ozturk S, Phillips SJ, Sprigg N, Szatmari S, Wardlaw JM, Bath PM; ENOS Investigators.

J Stroke Cerebrovasc Dis. 2016 May;25(5):1017-1026. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.010. Epub 2016 Feb 4.

13.

Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis.

Krishnan K, Scutt P, Woodhouse L, Adami A, Becker JL, Berge E, Cala LA, Casado AM, Caso V, Chen C, Christensen H, Collins R, Czlonkowska A, Dineen RA, Gommans J, Koumellis P, Lees KR, Ntaios G, Ozturk S, Phillips SJ, Pocock SJ, de Silva A, Sprigg N, Szatmari S, Wardlaw JM, Bath PM.

Stroke. 2016 Jan;47(1):44-52. doi: 10.1161/STROKEAHA.115.010368. Epub 2015 Dec 8.

PMID:
26645254
14.

Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial.

Woodhouse L, Scutt P, Krishnan K, Berge E, Gommans J, Ntaios G, Wardlaw J, Sprigg N, Bath PM; ENOS Investigators.

Stroke. 2015 Nov;46(11):3194-201. doi: 10.1161/STROKEAHA.115.009647. Epub 2015 Oct 13.

PMID:
26463698
15.

Cluster randomized controlled trial of TIA electronic decision support in primary care.

Ranta A, Dovey S, Weatherall M, O'Dea D, Gommans J, Tilyard M.

Neurology. 2015 Apr 14;84(15):1545-51. doi: 10.1212/WNL.0000000000001472. Epub 2015 Mar 20.

PMID:
25795645
16.

Stroke rehabilitation services in New Zealand: a survey of service configuration, capacity and guideline adherence.

McNaughton H, McRae A, Green G, Abernethy G, Gommans J.

N Z Med J. 2014 Sep 12;127(1402):10-9.

PMID:
25228417
17.

Emergency and stroke physician combined consensus statement on thrombolysis for acute stroke.

Ranta A, Bonning J, Fink J, Fleischer D, Gommans J, Jones P, Barber PA, Ardagh M.

N Z Med J. 2014 Apr 11;127(1392):113-4. Review.

PMID:
24806258
18.

The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial.

Gommans J, Yi Q, Eikelboom JW, Hankey GJ, Chen C, Rodgers H; VITATOPS trial study group.

BMC Geriatr. 2013 Sep 3;13:88. doi: 10.1186/1471-2318-13-88.

19.

Stroke thrombolysis in patients taking dabigatran.

Jayathissa S, Gommans J, Harper P.

Intern Med J. 2013 Jul;43(7):826-8. doi: 10.1111/imj.12182. Review.

PMID:
23841763
20.

Transient ischaemic attacks: "mini-strokes" with major but preventable consequences.

Gommans J, Barber PA.

N Z Med J. 2013 Apr 5;126(1372):9-11. No abstract available.

PMID:
23793172
21.

Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis.

Hankey GJ, Ford AH, Yi Q, Eikelboom JW, Lees KR, Chen C, Xavier D, Navarro JC, Ranawaka UK, Uddin W, Ricci S, Gommans J, Schmidt R, Almeida OP, van Bockxmeer FM; VITATOPS Trial Study Group.

Stroke. 2013 Aug;44(8):2232-9. doi: 10.1161/STROKEAHA.113.001886. Epub 2013 Jun 13.

22.

Changes in the provision of transient ischaemic attack services in New Zealand 2008 to 2013.

Brownlee W, Ranta A, Dale-Gandar J, Bennett P, Gommans J, Fink J, Barber PA.

N Z Med J. 2014 Mar 7;127(1390):23-9.

PMID:
24670586
23.

An assessment of the Hua Oranga outcome instrument and comparison to other outcome measures in an intervention study with Maori and Pacific people following stroke.

Harwood M, Weatherall M, Talemaitoga A, Barber PA, Gommans J, Taylor W, McPherson K, McNaughton H.

N Z Med J. 2012 Oct 26;125(1364):57-67.

PMID:
23242398
24.

Effect of the neutral CLOTS 1 trial on the use of graduated compression stockings in the Efficacy of Nitric Oxide Stroke (ENOS) trial.

Ankolekar S, Renton C, Bereczki D, Sprigg N, Payne T, Gommans J, Berge E, Wardlaw J, Dennis MS, Bath PM; ENOS Trial Investigators.

J Neurol Neurosurg Psychiatry. 2013 Mar;84(3):342-7. doi: 10.1136/jnnp-2012-303396. Epub 2012 Oct 31.

PMID:
23117488
25.

Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.

Hankey GJ, Eikelboom JW, Yi Q, Lees KR, Chen C, Xavier D, Navarro JC, Ranawaka UK, Uddin W, Ricci S, Gommans J, Schmidt R; VITATOPS trial study group.

Lancet Neurol. 2012 Jun;11(6):512-20. doi: 10.1016/S1474-4422(12)70091-1. Epub 2012 May 2.

26.

Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial.

Hankey GJ, Eikelboom JW, Yi Q, Lees KR, Chen C, Xavier D, Navarro JC, Ranawaka UK, Uddin W, Ricci S, Gommans J, Schmidt R; VITAmins TO Prevent Stroke (VITATOPS) Trial Study Group.

Stroke. 2012 Jun;43(6):1572-7. doi: 10.1161/STROKEAHA.111.641613. Epub 2012 Apr 3.

PMID:
22474057
27.

Taking charge after stroke: promoting self-directed rehabilitation to improve quality of life--a randomized controlled trial.

Harwood M, Weatherall M, Talemaitoga A, Barber PA, Gommans J, Taylor W, McPherson K, McNaughton H.

Clin Rehabil. 2012 Jun;26(6):493-501. doi: 10.1177/0269215511426017. Epub 2011 Nov 15.

PMID:
22087047
28.

Stroke Services in New Zealand: should where you live determine the quality of stroke care you receive?

Gommans J.

N Z Med J. 2011 Aug 12;124(1340):10-2. No abstract available.

PMID:
21952380
29.

Managing acute medical admissions: a survey of acute medical services and medical assessment and planning units in New Zealand.

Providence C, Gommans J, Burns A.

Intern Med J. 2012 Jan;42(1):51-6. doi: 10.1111/j.1445-5994.2010.02331.x. Epub 2010 Jul 30.

PMID:
20681959
30.

Transient ischaemic attack services in New Zealand.

Brownlee WJ, Fergus L, Bennett P, Gommans J, Fink J, Barber PA.

N Z Med J. 2009 Jul 24;122(1299):21-7.

PMID:
19684643
31.

Preventing strokes: the assessment and management of people with transient ischaemic attack.

Gommans J, Barber PA, Fink J.

N Z Med J. 2009 Apr 24;122(1293):3556. Review.

PMID:
19448791
32.

Acute stroke services in New Zealand: changes between 2001 and 2007.

Barber PA, Gommans J, Fink J, Hanger HC, Bennett P, Ataman N.

N Z Med J. 2008 Nov 7;121(1285):46-51.

PMID:
19079436
33.

VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444).

VITATOPS Trial Study Group, Hankey GJ, Algra A, Chen C, Wong MC, Cheung R, Wong L, Divjak I, Ferro J, de Freitas G, Gommans J, Groppa S, Hill M, Spence D, Lees K, Lisheng L, Navarro J, Ranawaka U, Ricci S, Schmidt R, Slivka A, Tan K, Tsiskaridze A, Uddin W, Vanhooren G, Xavier D, Armitage J, Hobbs M, Le M, Sudlow C, Wheatley K, Yi Q, Bulder M, Eikelboom JW, Hankey GJ, Ho WK, Jamrozik K, Klijn K, Koedam E, Langton P, Nijboer E, Tuch P, Pizzi J, Tang M, Antenucci M, Chew Y, Chinnery D, Cockayne C, Loh K, McMullin L, Smith F, Schmidt R, Chen C, Wong MC, de Freitas G, Hankey GJ, Loh K, Song S.

Int J Stroke. 2007 May;2(2):144-50. doi: 10.1111/j.1747-4949.2007.00111.x.

PMID:
18705976
34.

Rehabilitation after stroke: changes between 2002 and 2007 in services provided by district health boards in New Zealand.

Gommans J, Barber PA, Hanger HC, Bennett P.

N Z Med J. 2008 May 23;121(1274):26-33.

PMID:
18535639
35.

Improving the quality of written prescriptions in a general hospital: the influence of 10 years of serial audits and targeted interventions.

Gommans J, McIntosh P, Bee S, Allan W.

Intern Med J. 2008 Apr;38(4):243-8. doi: 10.1111/j.1445-5994.2007.01518.x. Epub 2008 Feb 19.

PMID:
18298560
36.

Management of hypertension in the oldest old: a study in primary care in New Zealand.

Senior H, Anderson CS, Chen MH, Haydon R, Walker D, Fourie D, Lillis S, Gommans J.

Age Ageing. 2006 Mar;35(2):178-82. Epub 2006 Jan 23.

PMID:
16431851
37.

Management problems of spontaneous ICH.

McNaughton H, Barber PA, Gommans J, Nowitz M.

Hosp Med. 2005 Apr;66(4):229-34. Review.

PMID:
15889873
38.
39.

Tissue plasminogen activator approved for stroke.

Barber A, Gommans J.

N Z Med J. 2005 May 6;118(1214):U1432. No abstract available.

PMID:
15886728
40.

Stroke care in New Zealand: a team game where everyone needs to run with the ball.

Gommans J.

N Z Med J. 2004 Mar 12;117(1190):U791. No abstract available.

PMID:
15107894
41.

Coping with severe acute respiratory syndrome: a personal view of the good, the bad and the ugly.

Gommans J.

N Z Med J. 2003 Jun 6;116(1175):U465. No abstract available.

PMID:
12838360
42.

Stroke rehabilitation services in New Zealand.

Gommans J, Barber A, McNaughton H, Hanger C, Bennett P, Spriggs D, Baskett J.

N Z Med J. 2003 May 16;116(1174):U435.

PMID:
12766781
43.

The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion.

Shoaib M, Gommans J, Morley A, Stolerman IP, Grailhe R, Changeux JP.

Neuropharmacology. 2002 Mar;42(4):530-9.

PMID:
11955523
44.

Acute stroke services in New Zealand.

Barber PA, Anderson NE, Bennett P, Gommans J.

N Z Med J. 2002 Jan 25;115(1146):3-6.

PMID:
11936348
45.

Two-lever drug-drug discrimination with the 5-HT1 receptor agonists flesinoxan and eltoprazine.

Gommans J, Hijzen TH, Maes RA, Olivier B.

Int J Neuropsychopharmacol. 2000 Sep;3(3):221-228.

PMID:
11343599
46.

Effects of drug discrimination history on anti-punishment properties of chlordiazepoxide in rats.

Pattij T, Hijzen TH, Gommans J, Maes RA, Olivier B.

Pharmacol Biochem Behav. 2000 Nov;67(3):621-7.

PMID:
11164094
47.

Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice.

Gommans J, Stolerman IP, Shoaib M.

Neuropharmacology. 2000 Oct;39(13):2840-7.

PMID:
11044754
48.

Discriminative stimulus properties of alprazolam.

Gommans J, Hijzen TH, Maes RA, Olivier B.

Psychopharmacology (Berl). 2000 Feb;148(2):146-52.

PMID:
10663429
49.

Discriminative stimulus properties of mCPP and alprazolam are not mediated by anxiety.

Gommans J, Hijzen TH, Pattij T, van der Gugten J, Olivier B.

Pharmacol Biochem Behav. 1999 Oct;64(2):385-7.

PMID:
10515318
50.

Stimulus properties of the selective 5-HT reuptake inhibitor fluvoxamine in conditioned taste aversion procedures.

Olivier B, Gommans J, van der Gugten J, Bouwknecht JA, Herremans AH, Patty T, Hijzen TH.

Pharmacol Biochem Behav. 1999 Oct;64(2):213-20.

PMID:
10515294

Supplemental Content

Loading ...
Support Center